A comparison of the stability of doxorubicin and daunorubicin in solid state

The degradation of doxorubicin and daunorubcin in the solid state was studied using an HPLC method with UV detection (LiChrospher RP-18, 5 μm, 250 mm × 4 mm; mobile phase: acetonitrile-solution A 1:1, v/v (solution A: 2.88 g of laurisulfate sodium and 1.6 ml of phosphoric acid(V) in 1000 ml); flow r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical and biomedical analysis 2009-11, Vol.50 (4), p.576-579
Hauptverfasser: Cielecka-Piontek, J., Jelińska, A., Zając, M., Sobczak, M., Bartold, A., Oszczapowicz, I.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 579
container_issue 4
container_start_page 576
container_title Journal of pharmaceutical and biomedical analysis
container_volume 50
creator Cielecka-Piontek, J.
Jelińska, A.
Zając, M.
Sobczak, M.
Bartold, A.
Oszczapowicz, I.
description The degradation of doxorubicin and daunorubcin in the solid state was studied using an HPLC method with UV detection (LiChrospher RP-18, 5 μm, 250 mm × 4 mm; mobile phase: acetonitrile-solution A 1:1, v/v (solution A: 2.88 g of laurisulfate sodium and 1.6 ml of phosphoric acid(V) in 1000 ml); flow rate – 1.4 ml min −1; UV detection – 254 nm). The degradation of doxorubicin was a first-order reaction depending on the substrate concentration and daunorubicin degraded according to the kinetic model of autocatalysis. The dependence ln k i = f(1/ T) was described by the equations ln k DOX = 40.0 ± 15.6 – (19804 ± 5682) (1/ T) and ln k DAU = 35.9 ± 11.3 – (16581 ± 3972) (1/ T) at 76.4% RH. The dependence ln k i = f(RH%) was described by the equations ln k DOX = (8.80 ± 3.60) × 10 −2 (RH%) – (21.50 ± 2.57) and ln k DAU = (6.63 ± 1.22) × 10 −2 (RH%) – (13.35 ± 1.68). The thermodynamic parameters ( E a, Δ H ≠a , Δ S ≠a ) of the degradation of doxorubicin and daunorubicin were calculated. Although the degradation of doxorubicin was slower at increased temperature (353–373 K) and relative air humidity (50.9–90.0%), the differences between the influence of temperature and relative air humidity on the stability doxorubicin and of daunorubicin were not significant.
doi_str_mv 10.1016/j.jpba.2008.12.029
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733574570</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0731708508006560</els_id><sourcerecordid>733574570</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-789251c794431ff1d337cf73bf98cce26d230281b487c50c96b8dec387eba4273</originalsourceid><addsrcrecordid>eNp9kE1LxDAQhoMo7rr6BzxIL-KpNZO0TQJeZPELFrwoeAtpkmKWbrMmrbj_3pYt600YGBie92V4ELoEnAGG8nadrbeVygjGPAOSYSKO0Bw4oykp849jNMeMQsowL2boLMY1xrgAkZ-iGQgQBQeYo9V9ov1mq4KLvk18nXSfNomdqlzjut14MP7Hh75y2rWJak1iVN8eDsNE3zgzRjp7jk5q1UR7Me0Fen98eFs-p6vXp5fl_SrVlBddyrggBWgm8pxCXYOhlOma0aoWXGtLSkMoJhyqnDNdYC3Kihs7ZJmtVE4YXaCbfe82-K_exk5uXNS2aVRrfR8lo7RgecHwQJI9qYOPMdhaboPbqLCTgOUoUa7lKFGOEiUQOUgcQldTfV9trPmLTNYG4HoCVNSqqYNqtYsHjoBgouR84O72nB1kfDsbZNTOttoaF6zupPHuvz9-Af_mj5s</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733574570</pqid></control><display><type>article</type><title>A comparison of the stability of doxorubicin and daunorubicin in solid state</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Cielecka-Piontek, J. ; Jelińska, A. ; Zając, M. ; Sobczak, M. ; Bartold, A. ; Oszczapowicz, I.</creator><creatorcontrib>Cielecka-Piontek, J. ; Jelińska, A. ; Zając, M. ; Sobczak, M. ; Bartold, A. ; Oszczapowicz, I.</creatorcontrib><description>The degradation of doxorubicin and daunorubcin in the solid state was studied using an HPLC method with UV detection (LiChrospher RP-18, 5 μm, 250 mm × 4 mm; mobile phase: acetonitrile-solution A 1:1, v/v (solution A: 2.88 g of laurisulfate sodium and 1.6 ml of phosphoric acid(V) in 1000 ml); flow rate – 1.4 ml min −1; UV detection – 254 nm). The degradation of doxorubicin was a first-order reaction depending on the substrate concentration and daunorubicin degraded according to the kinetic model of autocatalysis. The dependence ln k i = f(1/ T) was described by the equations ln k DOX = 40.0 ± 15.6 – (19804 ± 5682) (1/ T) and ln k DAU = 35.9 ± 11.3 – (16581 ± 3972) (1/ T) at 76.4% RH. The dependence ln k i = f(RH%) was described by the equations ln k DOX = (8.80 ± 3.60) × 10 −2 (RH%) – (21.50 ± 2.57) and ln k DAU = (6.63 ± 1.22) × 10 −2 (RH%) – (13.35 ± 1.68). The thermodynamic parameters ( E a, Δ H ≠a , Δ S ≠a ) of the degradation of doxorubicin and daunorubicin were calculated. Although the degradation of doxorubicin was slower at increased temperature (353–373 K) and relative air humidity (50.9–90.0%), the differences between the influence of temperature and relative air humidity on the stability doxorubicin and of daunorubicin were not significant.</description><identifier>ISSN: 0731-7085</identifier><identifier>EISSN: 1873-264X</identifier><identifier>DOI: 10.1016/j.jpba.2008.12.029</identifier><identifier>PMID: 19195811</identifier><identifier>CODEN: JPBADA</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Analysis ; Analytical, structural and metabolic biochemistry ; Antibiotics, Antineoplastic - chemistry ; Biological and medical sciences ; Chromatography, High Pressure Liquid - methods ; Daunorubicin ; Daunorubicin - chemistry ; Doxorubicin ; Doxorubicin - chemistry ; Drug Stability ; Fundamental and applied biological sciences. Psychology ; General pharmacology ; HPLC ; Humidity ; Kinetics ; Medical sciences ; Pharmacology. Drug treatments ; Solid State ; Spectrophotometry, Ultraviolet - methods ; Stability ; Temperature ; Thermodynamics</subject><ispartof>Journal of pharmaceutical and biomedical analysis, 2009-11, Vol.50 (4), p.576-579</ispartof><rights>2008 Elsevier B.V.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-789251c794431ff1d337cf73bf98cce26d230281b487c50c96b8dec387eba4273</citedby><cites>FETCH-LOGICAL-c385t-789251c794431ff1d337cf73bf98cce26d230281b487c50c96b8dec387eba4273</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0731708508006560$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23909,23910,25118,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21979688$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19195811$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cielecka-Piontek, J.</creatorcontrib><creatorcontrib>Jelińska, A.</creatorcontrib><creatorcontrib>Zając, M.</creatorcontrib><creatorcontrib>Sobczak, M.</creatorcontrib><creatorcontrib>Bartold, A.</creatorcontrib><creatorcontrib>Oszczapowicz, I.</creatorcontrib><title>A comparison of the stability of doxorubicin and daunorubicin in solid state</title><title>Journal of pharmaceutical and biomedical analysis</title><addtitle>J Pharm Biomed Anal</addtitle><description>The degradation of doxorubicin and daunorubcin in the solid state was studied using an HPLC method with UV detection (LiChrospher RP-18, 5 μm, 250 mm × 4 mm; mobile phase: acetonitrile-solution A 1:1, v/v (solution A: 2.88 g of laurisulfate sodium and 1.6 ml of phosphoric acid(V) in 1000 ml); flow rate – 1.4 ml min −1; UV detection – 254 nm). The degradation of doxorubicin was a first-order reaction depending on the substrate concentration and daunorubicin degraded according to the kinetic model of autocatalysis. The dependence ln k i = f(1/ T) was described by the equations ln k DOX = 40.0 ± 15.6 – (19804 ± 5682) (1/ T) and ln k DAU = 35.9 ± 11.3 – (16581 ± 3972) (1/ T) at 76.4% RH. The dependence ln k i = f(RH%) was described by the equations ln k DOX = (8.80 ± 3.60) × 10 −2 (RH%) – (21.50 ± 2.57) and ln k DAU = (6.63 ± 1.22) × 10 −2 (RH%) – (13.35 ± 1.68). The thermodynamic parameters ( E a, Δ H ≠a , Δ S ≠a ) of the degradation of doxorubicin and daunorubicin were calculated. Although the degradation of doxorubicin was slower at increased temperature (353–373 K) and relative air humidity (50.9–90.0%), the differences between the influence of temperature and relative air humidity on the stability doxorubicin and of daunorubicin were not significant.</description><subject>Analysis</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Antibiotics, Antineoplastic - chemistry</subject><subject>Biological and medical sciences</subject><subject>Chromatography, High Pressure Liquid - methods</subject><subject>Daunorubicin</subject><subject>Daunorubicin - chemistry</subject><subject>Doxorubicin</subject><subject>Doxorubicin - chemistry</subject><subject>Drug Stability</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>General pharmacology</subject><subject>HPLC</subject><subject>Humidity</subject><subject>Kinetics</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Solid State</subject><subject>Spectrophotometry, Ultraviolet - methods</subject><subject>Stability</subject><subject>Temperature</subject><subject>Thermodynamics</subject><issn>0731-7085</issn><issn>1873-264X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LxDAQhoMo7rr6BzxIL-KpNZO0TQJeZPELFrwoeAtpkmKWbrMmrbj_3pYt600YGBie92V4ELoEnAGG8nadrbeVygjGPAOSYSKO0Bw4oykp849jNMeMQsowL2boLMY1xrgAkZ-iGQgQBQeYo9V9ov1mq4KLvk18nXSfNomdqlzjut14MP7Hh75y2rWJak1iVN8eDsNE3zgzRjp7jk5q1UR7Me0Fen98eFs-p6vXp5fl_SrVlBddyrggBWgm8pxCXYOhlOma0aoWXGtLSkMoJhyqnDNdYC3Kihs7ZJmtVE4YXaCbfe82-K_exk5uXNS2aVRrfR8lo7RgecHwQJI9qYOPMdhaboPbqLCTgOUoUa7lKFGOEiUQOUgcQldTfV9trPmLTNYG4HoCVNSqqYNqtYsHjoBgouR84O72nB1kfDsbZNTOttoaF6zupPHuvz9-Af_mj5s</recordid><startdate>20091101</startdate><enddate>20091101</enddate><creator>Cielecka-Piontek, J.</creator><creator>Jelińska, A.</creator><creator>Zając, M.</creator><creator>Sobczak, M.</creator><creator>Bartold, A.</creator><creator>Oszczapowicz, I.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20091101</creationdate><title>A comparison of the stability of doxorubicin and daunorubicin in solid state</title><author>Cielecka-Piontek, J. ; Jelińska, A. ; Zając, M. ; Sobczak, M. ; Bartold, A. ; Oszczapowicz, I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-789251c794431ff1d337cf73bf98cce26d230281b487c50c96b8dec387eba4273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Analysis</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Antibiotics, Antineoplastic - chemistry</topic><topic>Biological and medical sciences</topic><topic>Chromatography, High Pressure Liquid - methods</topic><topic>Daunorubicin</topic><topic>Daunorubicin - chemistry</topic><topic>Doxorubicin</topic><topic>Doxorubicin - chemistry</topic><topic>Drug Stability</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>General pharmacology</topic><topic>HPLC</topic><topic>Humidity</topic><topic>Kinetics</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Solid State</topic><topic>Spectrophotometry, Ultraviolet - methods</topic><topic>Stability</topic><topic>Temperature</topic><topic>Thermodynamics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cielecka-Piontek, J.</creatorcontrib><creatorcontrib>Jelińska, A.</creatorcontrib><creatorcontrib>Zając, M.</creatorcontrib><creatorcontrib>Sobczak, M.</creatorcontrib><creatorcontrib>Bartold, A.</creatorcontrib><creatorcontrib>Oszczapowicz, I.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cielecka-Piontek, J.</au><au>Jelińska, A.</au><au>Zając, M.</au><au>Sobczak, M.</au><au>Bartold, A.</au><au>Oszczapowicz, I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A comparison of the stability of doxorubicin and daunorubicin in solid state</atitle><jtitle>Journal of pharmaceutical and biomedical analysis</jtitle><addtitle>J Pharm Biomed Anal</addtitle><date>2009-11-01</date><risdate>2009</risdate><volume>50</volume><issue>4</issue><spage>576</spage><epage>579</epage><pages>576-579</pages><issn>0731-7085</issn><eissn>1873-264X</eissn><coden>JPBADA</coden><abstract>The degradation of doxorubicin and daunorubcin in the solid state was studied using an HPLC method with UV detection (LiChrospher RP-18, 5 μm, 250 mm × 4 mm; mobile phase: acetonitrile-solution A 1:1, v/v (solution A: 2.88 g of laurisulfate sodium and 1.6 ml of phosphoric acid(V) in 1000 ml); flow rate – 1.4 ml min −1; UV detection – 254 nm). The degradation of doxorubicin was a first-order reaction depending on the substrate concentration and daunorubicin degraded according to the kinetic model of autocatalysis. The dependence ln k i = f(1/ T) was described by the equations ln k DOX = 40.0 ± 15.6 – (19804 ± 5682) (1/ T) and ln k DAU = 35.9 ± 11.3 – (16581 ± 3972) (1/ T) at 76.4% RH. The dependence ln k i = f(RH%) was described by the equations ln k DOX = (8.80 ± 3.60) × 10 −2 (RH%) – (21.50 ± 2.57) and ln k DAU = (6.63 ± 1.22) × 10 −2 (RH%) – (13.35 ± 1.68). The thermodynamic parameters ( E a, Δ H ≠a , Δ S ≠a ) of the degradation of doxorubicin and daunorubicin were calculated. Although the degradation of doxorubicin was slower at increased temperature (353–373 K) and relative air humidity (50.9–90.0%), the differences between the influence of temperature and relative air humidity on the stability doxorubicin and of daunorubicin were not significant.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>19195811</pmid><doi>10.1016/j.jpba.2008.12.029</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0731-7085
ispartof Journal of pharmaceutical and biomedical analysis, 2009-11, Vol.50 (4), p.576-579
issn 0731-7085
1873-264X
language eng
recordid cdi_proquest_miscellaneous_733574570
source MEDLINE; Elsevier ScienceDirect Journals
subjects Analysis
Analytical, structural and metabolic biochemistry
Antibiotics, Antineoplastic - chemistry
Biological and medical sciences
Chromatography, High Pressure Liquid - methods
Daunorubicin
Daunorubicin - chemistry
Doxorubicin
Doxorubicin - chemistry
Drug Stability
Fundamental and applied biological sciences. Psychology
General pharmacology
HPLC
Humidity
Kinetics
Medical sciences
Pharmacology. Drug treatments
Solid State
Spectrophotometry, Ultraviolet - methods
Stability
Temperature
Thermodynamics
title A comparison of the stability of doxorubicin and daunorubicin in solid state
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T01%3A46%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20comparison%20of%20the%20stability%20of%20doxorubicin%20and%20daunorubicin%20in%20solid%20state&rft.jtitle=Journal%20of%20pharmaceutical%20and%20biomedical%20analysis&rft.au=Cielecka-Piontek,%20J.&rft.date=2009-11-01&rft.volume=50&rft.issue=4&rft.spage=576&rft.epage=579&rft.pages=576-579&rft.issn=0731-7085&rft.eissn=1873-264X&rft.coden=JPBADA&rft_id=info:doi/10.1016/j.jpba.2008.12.029&rft_dat=%3Cproquest_cross%3E733574570%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733574570&rft_id=info:pmid/19195811&rft_els_id=S0731708508006560&rfr_iscdi=true